These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 18759374)

  • 1. Molecular targeting of the PKC-beta inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression.
    Verdelli D; Nobili L; Todoerti K; Intini D; Cosenza M; Civallero M; Bertacchini J; Deliliers GL; Sacchi S; Lombardi L; Neri A
    Hematol Oncol; 2009 Mar; 27(1):23-30. PubMed ID: 18759374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic profiling of enzastaurin-treated B cell lymphoma RL cells.
    Civallero M; Cosenza M; Neri A; Bari A
    Hematol Oncol; 2011 Sep; 29(3):154-6. PubMed ID: 21922509
    [No Abstract]   [Full Text] [Related]  

  • 3. Concomitant downregulation of proliferation/survival pathways dependent on FGF-R3, JAK2 and BCMA in human multiple myeloma cells by multi-kinase targeting.
    Cassinelli G; Ronchetti D; Laccabue D; Mattioli M; Cuccuru G; Favini E; Nicolini V; Greco A; Neri A; Zunino F; Lanzi C
    Biochem Pharmacol; 2009 Nov; 78(9):1139-47. PubMed ID: 19555670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lenalidomide downregulates the cell survival factor, interferon regulatory factor-4, providing a potential mechanistic link for predicting response.
    Lopez-Girona A; Heintel D; Zhang LH; Mendy D; Gaidarova S; Brady H; Bartlett JB; Schafer PH; Schreder M; Bolomsky A; Hilgarth B; Zojer N; Gisslinger H; Ludwig H; Daniel T; Jäger U; Chopra R
    Br J Haematol; 2011 Aug; 154(3):325-36. PubMed ID: 21707574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oral protein-kinase C beta inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines.
    Neri A; Marmiroli S; Tassone P; Lombardi L; Nobili L; Verdelli D; Civallero M; Cosenza M; Bertacchini J; Federico M; De Pol A; Deliliers GL; Sacchi S
    Leuk Lymphoma; 2008 Jul; 49(7):1374-83. PubMed ID: 18452078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells.
    Lee KW; Kim SG; Kim HP; Kwon E; You J; Choi HJ; Park JH; Kang BC; Im SA; Kim TY; Kim WH; Bang YJ
    Cancer Res; 2008 Mar; 68(6):1916-26. PubMed ID: 18339873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of PKCbeta in the malignant tumors and enzastaurin, a PKCbeta inhibitor].
    Li XY; Chen XG
    Yao Xue Xue Bao; 2009 May; 44(5):449-55. PubMed ID: 19618717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Didox, a ribonucleotide reductase inhibitor, induces apoptosis and inhibits DNA repair in multiple myeloma cells.
    Raje N; Kumar S; Hideshima T; Ishitsuka K; Yasui H; Chhetri S; Vallet S; Vonescu E; Shiraishi N; Kiziltepe T; Elford HL; Munshi NC; Anderson KC
    Br J Haematol; 2006 Oct; 135(1):52-61. PubMed ID: 16925573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of protein kinase C sensitise multiple myeloma cells to common genotoxic drugs.
    Baumann P; Armann J; Mandl-Weber S; Grün G; Oduncu F; Schmidmaier R
    Eur J Haematol; 2008 Jan; 80(1):37-45. PubMed ID: 18028419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature.
    Olivier S; Close P; Castermans E; de Leval L; Tabruyn S; Chariot A; Malaise M; Merville MP; Bours V; Franchimont N
    Mol Pharmacol; 2006 May; 69(5):1615-23. PubMed ID: 16497877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of lymphocyte function associated antigen 1 by LFA878 induces apoptosis in multiple myeloma cells and is associated with downregulation of the focal adhesion kinase/phosphatidylinositol 3 kinase/Akt pathway.
    Schmidmaier R; Mandl-Weber S; Gaul L; Baumann P; Bumeder I; Straka C; Emmerich B
    Int J Oncol; 2007 Oct; 31(4):969-76. PubMed ID: 17786331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting PKC in multiple myeloma: in vitro and in vivo effects of the novel, orally available small-molecule inhibitor enzastaurin (LY317615.HCl).
    Podar K; Raab MS; Zhang J; McMillin D; Breitkreutz I; Tai YT; Lin BK; Munshi N; Hideshima T; Chauhan D; Anderson KC
    Blood; 2007 Feb; 109(4):1669-77. PubMed ID: 17023575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in multiple myeloma cells through transcriptional repression and down-regulation of Mcl-1.
    Gojo I; Zhang B; Fenton RG
    Clin Cancer Res; 2002 Nov; 8(11):3527-38. PubMed ID: 12429644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzastaurin, a protein kinase Cbeta- selective inhibitor, and its potential application as an anticancer agent in lung cancer.
    Herbst RS; Oh Y; Wagle A; Lahn M
    Clin Cancer Res; 2007 Aug; 13(15 Pt 2):s4641-6. PubMed ID: 17671157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
    Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
    Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer: An unexpected addiction.
    Shaughnessy JD
    Nature; 2008 Jul; 454(7201):172-3. PubMed ID: 18615074
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene-expression profiling during curcumin-induced apoptosis reveals downregulation of CXCR4.
    Skommer J; Wlodkowic D; Pelkonen J
    Exp Hematol; 2007 Jan; 35(1):84-95. PubMed ID: 17198877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting PKC: a novel role for beta-catenin in ER stress and apoptotic signaling.
    Raab MS; Breitkreutz I; Tonon G; Zhang J; Hayden PJ; Nguyen T; Fruehauf JH; Lin BK; Chauhan D; Hideshima T; Munshi NC; Anderson KC; Podar K
    Blood; 2009 Feb; 113(7):1513-21. PubMed ID: 19018094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profile of multiple myeloma cell line treated by realgar.
    Wang MC; Liu SX; Liu PB
    J Exp Clin Cancer Res; 2006 Jun; 25(2):243-9. PubMed ID: 16918137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzastaurin.
    Ma S; Rosen ST
    Curr Opin Oncol; 2007 Nov; 19(6):590-5. PubMed ID: 17906457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.